Petr Bušek

976 total citations
43 papers, 746 citations indexed

About

Petr Bušek is a scholar working on Oncology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Petr Bušek has authored 43 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 16 papers in Cellular and Molecular Neuroscience and 12 papers in Molecular Biology. Recurrent topics in Petr Bušek's work include Peptidase Inhibition and Analysis (26 papers), Neuropeptides and Animal Physiology (16 papers) and Diabetes Treatment and Management (10 papers). Petr Bušek is often cited by papers focused on Peptidase Inhibition and Analysis (26 papers), Neuropeptides and Animal Physiology (16 papers) and Diabetes Treatment and Management (10 papers). Petr Bušek collaborates with scholars based in Czechia, United States and Russia. Petr Bušek's co-authors include Aleksi Šedo, Radek Malı́k, Eva Balážiová, E Kr̆epela, Jonathan S. Duke‐Cohan, Jarmila Stremenova Spegarova, Petr Hrabal, P Frič, Jan Konvalinka and Robert Tomáš and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Petr Bušek

40 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petr Bušek Czechia 17 530 279 245 210 126 43 746
B.K. Mohan Raj United States 7 554 1.0× 277 1.0× 289 1.2× 209 1.0× 127 1.0× 10 734
Christina Puri Austria 8 459 0.9× 280 1.0× 163 0.7× 53 0.3× 75 0.6× 8 674
Silvia Volpe Italy 10 549 1.0× 724 2.6× 367 1.5× 71 0.3× 53 0.4× 11 1.2k
Hiromasa Tsuiki Japan 13 202 0.4× 521 1.9× 157 0.6× 62 0.3× 64 0.5× 20 903
Barbara Tanno Italy 19 423 0.8× 737 2.6× 268 1.1× 28 0.1× 31 0.2× 45 1.1k
Sonia Pagliardini Italy 17 312 0.6× 610 2.2× 133 0.5× 77 0.4× 28 0.2× 25 988
Zoya Gluzman‐Poltorak Israel 13 274 0.5× 532 1.9× 122 0.5× 299 1.4× 38 0.3× 18 762
María Teresa Calvo Spain 12 235 0.4× 625 2.2× 84 0.3× 78 0.4× 48 0.4× 17 1.0k
Kara White Moyes United States 12 387 0.7× 416 1.5× 164 0.7× 55 0.3× 194 1.5× 17 924
Federica Ruffini Italy 20 461 0.9× 637 2.3× 197 0.8× 81 0.4× 49 0.4× 30 936

Countries citing papers authored by Petr Bušek

Since Specialization
Citations

This map shows the geographic impact of Petr Bušek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Bušek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Bušek more than expected).

Fields of papers citing papers by Petr Bušek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Bušek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Bušek. The network helps show where Petr Bušek may publish in the future.

Co-authorship network of co-authors of Petr Bušek

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Bušek. A scholar is included among the top collaborators of Petr Bušek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Bušek. Petr Bušek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vetrík, Miroslav, Jan Kučka, Jan Konvalinka, et al.. (2025). OS02.5.A PRECLINICAL EVALUATION OF ALPHA-KETOAMIDE-BASED FAP RADIOLIGANDS FOR TARGETING BRAIN METASTASES. Neuro-Oncology. 27(Supplement_3). iii12–iii12.
2.
Slabý, Ondřej, et al.. (2024). Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells. Biomarker Research. 12(1). 15–15. 10 indexed citations
3.
Čermáková, Kateřina, et al.. (2024). Sensitive quantification of fibroblast activation protein and high-throughput screening for inhibition by FDA-approved compounds. European Journal of Medicinal Chemistry. 280. 116948–116948. 1 indexed citations
4.
Kejík, Zdeněk, David Sýkora, Kateřina Veselá, et al.. (2023). Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting. Bioorganic Chemistry. 141. 106816–106816. 1 indexed citations
5.
Syrůček, Martin, Robert Tomáš, Zdislava Vaníčková, et al.. (2023). Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours. Pathology. 55(6). 806–817. 16 indexed citations
6.
Šroubek, Filip, John C. Widen, Matthew Bogyo, et al.. (2023). P15.03.B MOLECULARLY TARGETED PROTEASE-ACTIVATED PROBES FOR THE VISUALIZATION OF GLIOBLASTOMA: A COMPARISON WITH 5-ALA. Neuro-Oncology. 25(Supplement_2). ii109–ii110. 1 indexed citations
7.
Kejík, Zdeněk, Robert Kaplánek, Kateřina Veselá, et al.. (2022). New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity. Pharmaceutics. 14(8). 1712–1712. 4 indexed citations
8.
Bušek, Petr, et al.. (2020). Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1868(7). 140409–140409. 55 indexed citations
9.
Šáňa, Jiří, Petr Bušek, Pavel Fadrus, et al.. (2018). Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Scientific Reports. 8(1). 2836–2836. 40 indexed citations
10.
Bušek, Petr, et al.. (2017). Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas. Biomedical Papers. 161(3). 252–260. 15 indexed citations
11.
Bušek, Petr, Zdislava Vaníčková, Petr Hrabal, et al.. (2016). Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. Pancreatology. 16(5). 829–838. 31 indexed citations
12.
13.
Bušek, Petr, et al.. (2015). Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro. Tumor Biology. 36(8). 5873–5879. 56 indexed citations
14.
Bušek, Petr, Petr Hrabal, P Frič, & Aleksi Šedo. (2014). Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets. Histochemistry and Cell Biology. 143(5). 497–504. 29 indexed citations
15.
Krasulová, Eva, et al.. (2012). Autoimunitní limbická encefalitida asociovaná s LGI1 protilátkami. Neurologie pro praxi. 13(6). 343–346.
16.
Bušek, Petr, Jarmila Stremenova Spegarova, Eva Balážiová, et al.. (2012). Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity. The International Journal of Biochemistry & Cell Biology. 44(5). 738–747. 32 indexed citations
17.
Bušek, Petr. (2007). Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors - good or evil?. Frontiers in bioscience. 13(13). 2319–2319. 21 indexed citations
18.
Bušek, Petr, et al.. (2006). Expression and Function of Dipeptidyl Peptidase IV and Related Enzymes in Cancer. Advances in experimental medicine and biology. 575. 55–62. 4 indexed citations
19.
Šedo, Aleksi, et al.. (2004). 'Dipeptidyl peptidase-IV activity and/or structure homologs' (DASH) in growth-modulated glioma cell lines. Biological Chemistry. 385(6). 557–9. 9 indexed citations
20.
Bušek, Petr, Radek Malı́k, & Aleksi Šedo. (2003). Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. The International Journal of Biochemistry & Cell Biology. 36(3). 408–421. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B.K. Mohan Raj Breakdown of academic impact, for papers by Christina Puri Breakdown of academic impact, for papers by Silvia Volpe Breakdown of academic impact, for papers by Hiromasa Tsuiki Breakdown of academic impact, for papers by Barbara Tanno Breakdown of academic impact, for papers by Sonia Pagliardini Breakdown of academic impact, for papers by Zoya Gluzman‐Poltorak Breakdown of academic impact, for papers by María Teresa Calvo Breakdown of academic impact, for papers by Kara White Moyes Breakdown of academic impact, for papers by Federica Ruffini
Rankless by CCL
2026